BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:45 PM
 | 
Oct 19, 2007
 |  BC Extra  |  Clinical News

Malaria vaccine safe, immunogenic in infants

Researchers from the Barcelona Centre for International Health Research and colleagues published Phase I/IIb data in The Lancet demonstrating the safety and immunogenicity of the RTS,S/AS02D malaria vaccine candidate from GlaxoSmithKline (LSE:GSK; GSK). The double-blind...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >